Tag: #PlasmaTherapy
-

Plasma Therapy in aHUS Patient with SARS-CoV-2 Infection
Introduction Atypical Hemolytic Uremic Syndrome (aHUS) is a rare condition characterized by complement-mediated thrombotic microangiopathy. Patients with aHUS who contract SARS-CoV-2 face a heightened risk of disease recurrence due to complement system activation. However, the management of such cases remains an area of ongoing research. This article explores a recent case study where convalescent plasma…
